Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

The Role of Altruistic Values in Motivating Underrepresented Minority Students for Biomedicine.

Thoman DB, Brown ER, Mason AZ, Harmsen AG, Smith JL.

Bioscience. 2015 Feb 1;65(2):183-188.

2.

Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia.

Rynda-Apple A, Harmsen A, Erickson AS, Larson K, Morton RV, Richert LE, Harmsen AG.

Eur J Immunol. 2014 Nov;44(11):3263-72. doi: 10.1002/eji.201444582. Epub 2014 Sep 1.

3.

Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses.

Richert LE, Harmsen AL, Rynda-Apple A, Wiley JA, Servid AE, Douglas T, Harmsen AG.

Lymphat Res Biol. 2013 Dec;11(4):196-202. doi: 10.1089/lrb.2013.0015.

4.

CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.

Richert LE, Rynda-Apple A, Harmsen AL, Han S, Wiley JA, Douglas T, Larson K, Morton RV, Harmsen AG.

Eur J Immunol. 2014 Feb;44(2):397-408. doi: 10.1002/eji.201343587. Epub 2014 Jan 13.

5.

Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.

Patterson DP, Rynda-Apple A, Harmsen AL, Harmsen AG, Douglas T.

ACS Nano. 2013 Apr 23;7(4):3036-44. doi: 10.1021/nn4006544. Epub 2013 Apr 10.

6.

Resident alveolar macrophages are susceptible to and permissive of Coxiella burnetii infection.

Calverley M, Erickson S, Read AJ, Harmsen AG.

PLoS One. 2012;7(12):e51941. doi: 10.1371/journal.pone.0051941. Epub 2012 Dec 19.

7.

Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.

Rynda-Apple A, Dobrinen E, McAlpine M, Read A, Harmsen A, Richert LE, Calverley M, Pallister K, Voyich J, Wiley JA, Johnson B, Young M, Douglas T, Harmsen AG.

Am J Pathol. 2012 Jul;181(1):196-210. doi: 10.1016/j.ajpath.2012.03.018. Epub 2012 May 26.

8.

A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.

Richert LE, Servid AE, Harmsen AL, Rynda-Apple A, Han S, Wiley JA, Douglas T, Harmsen AG.

Vaccine. 2012 May 21;30(24):3653-65. doi: 10.1016/j.vaccine.2012.03.035. Epub 2012 Mar 28.

9.

Pneumocystis elicits a STAT6-dependent, strain-specific innate immune response and airway hyperresponsiveness.

Swain SD, Meissner NN, Siemsen DW, McInnerney K, Harmsen AG.

Am J Respir Cell Mol Biol. 2012 Mar;46(3):290-8. doi: 10.1165/rcmb.2011-0154OC. Epub 2011 Sep 29.

10.

Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.

Meissner N, Swain S, McInnerney K, Han S, Harmsen AG.

Am J Pathol. 2010 Jun;176(6):2806-18. doi: 10.2353/ajpath.2010.091158. Epub 2010 Apr 15.

11.

Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii.

Read AJ, Erickson S, Harmsen AG.

Infect Immun. 2010 Jul;78(7):3019-26. doi: 10.1128/IAI.00101-10. Epub 2010 Mar 29.

12.

Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection.

King QO, Lei B, Harmsen AG.

J Infect Dis. 2009 Aug 15;200(4):537-45. doi: 10.1086/600871.

13.

Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae.

Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG.

Am J Respir Cell Mol Biol. 2010 Apr;42(4):450-60. doi: 10.1165/rcmb.2007-0417OC. Epub 2009 Jun 11.

14.

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C.

Vaccine. 2009 Jan 22;27(4):530-41. doi: 10.1016/j.vaccine.2008.11.011. Epub 2008 Nov 19.

PMID:
19026705
15.
16.

Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo.

Kaiser CR, Flenniken ML, Gillitzer E, Harmsen AL, Harmsen AG, Jutila MA, Douglas T, Young MJ.

Int J Nanomedicine. 2007;2(4):715-33.

17.

Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.

Swain SD, Han S, Harmsen A, Shampeny K, Harmsen AG.

Am J Pathol. 2007 Sep;171(3):790-9. Epub 2007 Jul 19.

18.
19.

Type I interferon signaling and B cells maintain hemopoiesis during Pneumocystis infection of the lung.

Meissner N, Rutkowski M, Harmsen AL, Han S, Harmsen AG.

J Immunol. 2007 May 15;178(10):6604-15.

20.

Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs.

Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, Kusser K, Tighe MP, Klonowski KD, Lefrançois L, Cauley LS, Harmsen AG, Lund FE, Randall TD.

Immunity. 2006 Oct;25(4):643-54.

21.

Tritrichomonas foetus: pathogenesis of acute infection in normal, estradiol-treated, and stressed mice.

Rutkowski MR, Harmsen AG.

Exp Parasitol. 2007 Feb;115(2):143-59. Epub 2006 Oct 2.

PMID:
17014850
23.

Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia.

Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB.

Infect Immun. 2006 Dec;74(12):6528-39. Epub 2006 Aug 18.

24.

Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions.

Hall-Stoodley L, Watts G, Crowther JE, Balagopal A, Torrelles JB, Robison-Cox J, Bargatze RF, Harmsen AG, Crouch EC, Schlesinger LS.

Infect Immun. 2006 Jun;74(6):3587-96.

25.

Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture.

Flenniken ML, Willits DA, Harmsen AL, Liepold LO, Harmsen AG, Young MJ, Douglas T.

Chem Biol. 2006 Feb;13(2):161-70.

26.
27.

Uneven distribution of MHC class II epitopes within the influenza virus.

Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, Harmsen AG, Lund FE, Randall TD, Swain SL, Woodland DL.

Vaccine. 2006 Jan 23;24(4):457-67. Epub 2005 Aug 15.

PMID:
16140434
29.

Bronchoalveolar immune defense in cattle exposed to primary and secondary challenge with bovine viral diarrhea virus.

Silflow RM, Degel PM, Harmsen AG.

Vet Immunol Immunopathol. 2005 Jan 10;103(1-2):129-39.

PMID:
15626468
30.

Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Swain SD, Wright TW, Degel PM, Gigliotti F, Harmsen AG.

Infect Immun. 2004 Oct;72(10):5722-32.

31.

Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.

Steele C, Marrero L, Swain S, Harmsen AG, Zheng M, Brown GD, Gordon S, Shellito JE, Kolls JK.

J Exp Med. 2003 Dec 1;198(11):1677-88.

32.
33.
34.

Cryptosporidium parvum infection in gene-targeted B cell-deficient mice.

Chen W, Harp JA, Harmsen AG.

J Parasitol. 2003 Apr;89(2):391-3.

PMID:
12760662
36.

[Susceptibility and immune responses to Pneumocystis carinii infection in different strains of mice by contagious transmission].

An CL, Su XP, Harmsen AG.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2002;20(4):220-2. Chinese.

PMID:
12568024
37.

The role of CD8+ T cells in the pathogenesis of Pneumocystis carinii pneumonia in mice depleted of CD4+ T cells.

An CL, Su XP, Harmsen AG.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000;18(4):207-12.

PMID:
12567660
38.

IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection.

Qureshi MH, Harmsen AG, Garvy BA.

J Immunol. 2003 Jan 15;170(2):1002-9.

39.

Antiviral memory T-cell responses in the lung.

Woodland DL, Ely KH, Crowe SR, Tighe M, Brennan JW, Harmsen AG, Cauley LS.

Microbes Infect. 2002 Aug;4(10):1091-8. Review.

PMID:
12191659
40.

Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.

Gigliotti F, Haidaris CG, Wright TW, Harmsen AG.

Infect Immun. 2002 Mar;70(3):1069-74.

41.

Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.

Wiley JA, Hogan RJ, Woodland DL, Harmsen AG.

J Immunol. 2001 Sep 15;167(6):3293-9.

42.

Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.

Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, Woodland DL.

J Immunol. 2001 Feb 1;166(3):1813-22.

43.

Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Herzyk DJ, Gore ER, Polsky R, Nadwodny KL, Maier CC, Liu S, Hart TK, Harmsen AG, Bugelski PJ.

Infect Immun. 2001 Feb;69(2):1032-43.

44.

Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.

Wright TW, Notter RH, Wang Z, Harmsen AG, Gigliotti F.

Infect Immun. 2001 Feb;69(2):758-64.

45.
46.

Pulmonary immunobiology and inflammation in pulmonary diseases.

Crapo JD, Harmsen AG, Sherman MP, Musson RA.

Am J Respir Crit Care Med. 2000 Nov;162(5):1983-6. No abstract available.

PMID:
11069844
47.
48.

Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.

Bugelski PJ, Herzyk DJ, Rehm S, Harmsen AG, Gore EV, Williams DM, Maleeff BE, Badger AM, Truneh A, O'Brien SR, Macia RA, Wier PJ, Morgan DG, Hart TK.

Hum Exp Toxicol. 2000 Apr;19(4):230-43.

PMID:
10918514
49.

Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG.

J Clin Invest. 1999 Nov;104(9):1307-17.

50.

Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.

Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN.

Infect Immun. 1999 Jul;67(7):3452-60.

Supplemental Content

Loading ...
Support Center